Bank Of America Corp Crispr Therapeutics Ag Transaction History
Bank Of America Corp
- $1.19 Trillion
- Q3 2024
A detailed history of Bank Of America Corp transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Bank Of America Corp holds 1,081,763 shares of CRSP stock, worth $42.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,081,763
Previous 941,550
14.89%
Holding current value
$42.6 Million
Previous $50.9 Million
0.04%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CRSP
# of Institutions
489Shares Held
58.8MCall Options Held
1.09MPut Options Held
1.9M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$354 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA7.93MShares$312 Million0.07% of portfolio
-
State Street Corp Boston, MA2.99MShares$118 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$109 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$108 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.07B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....